Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Michael Benatar(University of Miami), Jeremy M. Shefner(Creighton University), Caroline McHutchison(University of Edinburgh), Joanne Wuu(University of Miami), Toby A. Ferguson(UK Dementia Research Institute), Jalayne J. Arias(University of California, San Francisco), Volkan Granit(Biohaven Pharmaceuticals (United States)), Petra Kaufman, Stephanie Fradette(Biogen (United States)), Katie Nicholson(Montreal Neurological Institute and Hospital), Ronald B. Postuma(Montreal General Hospital), Anne‐Laure Grignon(University of Miami), Corey T. McMillan(University of Pennsylvania), Christine Stanislaw(Emory University), Isabelle Le Ber(Inserm), Suzee Lee(University of Rochester), Martin R. Turner(King's College London), Ronald C. Petersen(Mayo Clinic), Murray Grossman(University of Pennsylvania), Kuldip D. Dave(Michael J. Fox Foundation), Michael McDermott(University of Leeds), Andrea Malaspina(Queen Mary University of London), Bradley F. Boeve(Mayo Clinic), Jonathan D. Rohrer(UK Dementia Research Institute), Howard J. Rosen, Christopher A. Ross(Johns Hopkins University), Stephanie Cosentino(Columbia University), Richard S. Finkel(Nemours Children's Clinic), Tania F. Gendron, Murray Grossman(University of Pennsylvania), Sharon Abrahams(University of Edinburgh), Amelie K. Gubitz, Mary-Kay Floeter(Biogen (United States))
Cited by 116
Related Papers
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k